UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Filed by the Registrant  ☒                              Filed by a party other than the Registrant  ☐

Check the appropriate box:

 

☐   

Preliminary Proxy Statement

☐   

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐

  

Definitive Proxy Statement

☒   

Definitive Additional Materials

☐   

Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

FUSE MEDICAL, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒   No fee required.
☐   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

☐   Fee paid previously with preliminary materials.
☐   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 

LOGO

Important Notice Regarding the Availability of Proxy Materials for the Annual Shareholder Meeting To Be Held on June 9, 2020
This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement and annual report, go to www.proxydocs.com/FZMD. To submit your proxy while visiting that site, you will need the 12-digit control number in the shaded gray box below.
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials may be distributed by making them available on the Internet. We have chosen to use these online procedures for our 2020 Annual Meeting and need YOUR participation.
If the you proxy want materials, to receive you a must paper request or e-mail one. copy There of to is no receive charge a paper to you package for requesting in time a for copy. this In year’s order annual before May meeting, 29, 2020. please make this request on or For a convenient way to VIEW Proxy Materials and VOTE online go to: www.proxydocs.com/FZMD
Proxy Materials Available to View or Receive: 1. Proxy Statement 2. Annual Report on Form 10-K Printed materials may be requested by one of the following methods: INTERNET www.investorelections.com/FZMD TELEPHONE (866) 648-8133
*E-MAIL paper@investorelections.com
You must use the 12-digit control number located in the shaded gray box below.
* If requesting material by e-mail, please send a blank e-mail with the 12-digit control number in the shaded gray box in the subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting material.
ACCOUNT NO. SHARES Fuse Medical, Inc. Notice of Annual Meeting Date: Tuesday, June 9, 2020
Time: 4:00 P.M. (Central Daylight Time) Place: Fuse Medical Headquarters 1565 N Central Expy, Suite 220 Richardson, TX 75080
The purpose of the Annual Meeting is to take action on the following proposals:
The Board of Directors recommends that you vote “FOR” each of the nominees listed below:
1. The election of four (4) directors to serve on the board of directors: 01 Renato V. Bosita, Jr., MD 04 Christopher C. Reeg
02 Mark W. Brooks 03 William E. McLaughlin, III
The Board of Directors recommends that you vote “FOR” the following:
2. The ratification of the appointment of Baker Tilly Virchow Krause, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
To transact such other business as may properly come before our Annual Meeting and any adjournment or postponement thereof.

Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Fuse Medical (PK) Charts.
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Fuse Medical (PK) Charts.